Molina Healthcare earnings release, July 22, 2026

Molina Healthcare, Inc. (MOH) · Form 8-K, Item 2.02 · Filed · SEC filing

News Release

Investor Contact:

Jeffrey Geyer,

Jeffrey.Geyer@molinahealthcare.com, 305-317-3012

Media Contact:

Caroline Zubieta,

Caroline.Zubieta@molinahealthcare.com, 562-542-1845

Molina Healthcare Reports Second Quarter 2026 Financial Results

Increases Full Year 2026 Earnings Guidance

Long Beach, Calif., July 22, 2026 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2026 GAAP income per diluted share of $1.19 and adjusted income per diluted share of $1.51. Financial results are summarized below:

Quarter Highlights

• As of June 30, 2026, the Company served approximately 4.9 million members.

• Premium revenue was approximately $10.2 billion for the second quarter of 2026.

• Second quarter 2026 GAAP income per diluted share was $1.19 and adjusted income per diluted share was $1.51.

• The Company increased its full year 2026 adjusted earnings guidance by $0.25 to at least $5.25 per diluted share.

“Our second quarter results and full year guidance reflect solid performance in our Medicaid and Medicare segments,” said Joseph Zubretsky, President and Chief Executive Officer. “The imbalance between Medicaid rates and medical cost trend appears to have stabilized and is well positioned to be corrected with future rate increases. This reinforces our belief that 2026 is the trough year for Medicaid pretax margins. We remain confident in our disciplined approach to medical cost management and believe the premium and EPS building blocks position us well for profitable growth in 2027.”

-MORE-

Molina Healthcare, Inc. Reports Second Quarter 2026 Financial Results

Page 2

July 22, 2026

Premium Revenue

Premium revenue was approximately $10.2 billion for the second quarter of 2026, a decrease of 6% year over year. The lower premium revenue reflects the impact of lower membership, partially offset by rate updates.

Net Income

GAAP net income for the second quarter of 2026 was $60 million, or $1.19 per diluted share, a decrease of 76% year over year. Adjusted net income for the second quarter of 2026 was $77 million, or $1.51 per diluted share, a decrease of 74% year over year. The decrease is attributed mainly to the lower premium revenues and increase in MCR.

Medical Care Ratio (MCR)

• The consolidated MCR for the second quarter of 2026 was 92.2%.

• The Medicaid MCR for the second quarter of 2026 was 92.7% and in line with the Company’s expectation, reflecting rate updates and stable medical cost trend.

• The Medicare MCR for the second quarter of 2026 was 90.7% and better than the Company’s expectation, reflecting lower medical cost trend and pricing implemented for 2026.

• The Marketplace MCR for the second quarter of 2026 was 88.9% and higher than the Company’s expectations, reflecting prior year risk adjustment and program integrity initiatives and the impact of current year unfavorable member acuity mix.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the second quarter of 2026 were 6.7% and 6.5%, respectively, reflecting continued operating discipline.

Balance Sheet

Cash and investments at the parent company were approximately $290 million as of June 30, 2026, compared to $223 million as of December 31, 2025.

Days in claims payable at June 30, 2026, was 44.

Cash Flow

Operating cash flow for the six months ended June 30, 2026, was $788 million, compared to an outflow of $112 million for the six months ended June 30, 2025. The increase compared to the prior year was driven mainly by the timing of government receivables and payables.

2026 Guidance

Premium revenue guidance for the full year is unchanged at approximately $42 billion.

The Company increased its full year 2026 GAAP earnings to at least $2.15 per diluted share and its full year 2026 adjusted earnings to at least $5.25 per diluted share. The increase to earnings guidance reflects first half performance in Medicaid. Based on developing medical cost trends, a $1.50 increase in earnings per share in Medicare is offset by a $1.50 decrease related to Marketplace. Excluding the downward revision in the Marketplace guidance, the full year guidance would have increased to $6.75 per share.

Full year guidance includes a loss of $1.50 per share due to the implementation of the new Florida Medicaid contract in the fourth quarter of 2026 and a loss of $1.00 per share due to performance of the traditional MAPD product, which the Company previously announced it will exit for 2027.

-MORE-

Molina Healthcare, Inc. Reports Second Quarter 2026 Financial Results

Page 3

July 22, 2026

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter ended June 30, 2026 results, at 8:00 a.m. Eastern Time on Thursday, July 23, 2026. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 8631129. A telephonic replay of the conference call will be available through Thursday, July 30, 2026, by dialing (855) 669-9658 and entering confirmation number 6469068.

A live audio broadcast of this conference call will be available on Molina Healthcare’s investor relations website, investors.molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Financial statements

Income Statement

Three months ended (in millions)

Three months ended – June 30, – 2026Three months ended – June 30, – 2025Six months ended – June 30, – 2026Six months ended – June 30, – 2025
Premium Revenue10,24410,86820,41621,496
Total Revenue10,87411,42721,67022,574
GAAP:Net Income6025574553
GAAP:EPS – Diluted1.194.751.4610.19
GAAP:Medical Care Ratio (MCR)92.290.491.689.8
GAAP:G&A Ratio6.76.26.96.6
GAAP:Pre-tax Margin0.82.80.63.2
Adjusted:Net Income77294197627
Adjusted:EPS – Diluted1.515.483.8611.56
Adjusted:G&A Ratio6.56.16.76.4
Adjusted:Pre-tax Margin13.31.33.6

Income Statement

Three Months Ended — UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (in millions)

Three Months Ended – June 30, – 2026Three Months Ended – June 30, – 2025Six Months Ended – June 30, – 2026Six Months Ended – June 30, – 2025
Revenue:Premium revenue10,24410,86820,41621,496
Revenue:Premium tax revenue5054311,009819
Revenue:Investment income101106199214
Revenue:Other revenue24224645
Revenue:Total revenue10,87411,42721,67022,574
Operating expenses:Medical care costs9,4409,82918,71019,308
Operating expenses:General and administrative expenses7247111,5031,485
Operating expenses:Premium tax expenses5054311,009819
Operating expenses:Depreciation and amortization405879106
Operating expenses:Impairment93
Operating expenses:Other20254850
Operating expenses:Total operating expenses10,72911,05421,44221,768
Operating expenses:Operating income145373228806
Operating expenses:Interest expense544810891
Operating expenses:Income before income tax expense91325120715
Operating expenses:Income tax expense317046162
Operating expenses:Net income6025574553
Operating expenses:Net income per share – Diluted1.194.751.4610.19
Operating expenses:Diluted weighted average shares outstanding51.353.751.254.3

Balance Sheet

December 31, — CONSOLIDATED BALANCE SHEETS (in millions)

June 30, – 2026 – Unaudited – ASSETSDecember 31, – 2025 – ASSETS
Current assets:Cash and cash equivalents4,9854,248
Current assets:Investments3,9304,008
Current assets:Receivables3,4853,533
Current assets:Prepaid expenses and other current assets528655
Current assets:Total current assets12,92812,444
Current assets:Property, equipment, and capitalized software, net311301
Current assets:Goodwill and intangible assets, net2,0822,195
Current assets:Restricted investments313299
Current assets:Deferred income taxes, net229178
Current assets:Other assets140147
Current assets:Total assets16,00315,564
Current liabilities:Medical claims and benefits payable4,8414,887
Current liabilities:Amounts due government agencies1,6511,326
Current liabilities:Accounts payable, accrued liabilities and other1,1391,093
Current liabilities:Deferred revenue6966
Current liabilities:Total current liabilities7,7007,372
Current liabilities:Long-term debt3,7693,766
Current liabilities:Finance lease liabilities184184
Current liabilities:Other long-term liabilities179173
Current liabilities:Total liabilities11,83211,495
Stockholders’ equity:Additional paid-in capital511452
Stockholders’ equity:Accumulated other comprehensive (loss) income-1615
Stockholders’ equity:Retained earnings3,6763,602
Stockholders’ equity:Total stockholders’ equity4,1714,069
Stockholders’ equity:Total liabilities and stockholders’ equity16,00315,564

Cash Flow

Six Months Ended — UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions)

Six Months Ended – June 30, – 2026Six Months Ended – June 30, – 2025
Operating activities:Net income74553
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Depreciation and amortization79106
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Deferred income taxes-4122
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Share-based compensation5930
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Impairment93
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Other, net-2
Changes in operating assets and liabilities:Receivables48-466
Changes in operating assets and liabilities:Prepaid expenses and other current assets910
Changes in operating assets and liabilities:Medical claims and benefits payable-46-50
Changes in operating assets and liabilities:Amounts due government agencies325-81
Changes in operating assets and liabilities:Accounts payable, accrued liabilities and other66-301
Changes in operating assets and liabilities:Deferred revenue3-59
Changes in operating assets and liabilities:Income taxes121124
Changes in operating assets and liabilities:Net cash provided by (used in) operating activities788-112
Investing activities:Purchases of investments-626-421
Investing activities:Proceeds from sales and maturities of investments672717
Investing activities:Purchases of property, equipment, and capitalized software-57-64
Investing activities:Net cash paid in business combinations-245
Investing activities:Other, net-818
Full release

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995... (truncated)ange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “assumes,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding the Company’s 2026 guidance and long-term performance outlook, trends with respect to rates, pretax margins, utilization, and medical costs, including the timing thereof and the anticipated impact on the Company’s business, and our management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the period ended March 31, 2026 filed with the SEC and Quarterly Report on Form 10-Q for the period ended June 30, 2026, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 22, 2026, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

-MORE-

Molina Healthcare, Inc. Reports Second Quarter 2026 Financial Results

Page 4

July 22, 2026

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Molina Healthcare earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.